KLRK1 and gestational diabetes: Therefore, we propose that the aberrant NK cell subtypes in GDM may also be related to the NKG2D signaling pathway, the interaction of NKG2D- NKG2D ligands may be a checkpoint to NK cell dysfunction in GDM patients.